EUVIMEDEUVIMED entdecken
Crossref

Psychological Distress, Antipsychotic Medications and Cardiovascular Risk Factors Among Patients With Schizophrenia

Tariq N Al-Dwaikat iD, Haya Khader Al-Samouri, Heyam Dalky, Shaher H Hamaideh iD, Mohammed ALBashtawy, Haitham Khatatbeh iD

Journal of Clinical Nursing · 2025-09 · 34 (9) · 3908-3919

DOI: 10.1111/jocn.17606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Nursing, online erschienen am 12.12.2024. Verfasst von Tariq N Al-Dwaikat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Nursing, Jordan University of Science and Technology, Irbid, Jordan. Hauptthemen laut MEDLINE: Antipsychotic Agents, Schizophrenia, Heart Disease Risk Factors, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: Deanship of Research, Jordan University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aims to assess the correlation between antipsychotic drug use, psychological distress and cardiovascular risk factors among patients with schizophrenia.

Methods

A cross‐sectional correlational design was used to obtain data from 143 patients with schizophrenia who were conveniently selected. Data were collected by assessing selected cardiovascular risk indicators blood pressure (BP), random blood sugar (RBS), body mass index (BMI), waist‐to‐height ratio (WtHR) and waist circumference (WC). A self‐administered questionnaire was used to collect sociodemographic data, clinical history and the 18‐item Psychological Stress Index for patients with schizophrenia.

Results

The use of antipsychotics was associated with increased cardiovascular risk factors including BP, BMI and WtHR. Atypical antipsychotic medications were associated with weight gain and obesity which increase the risk of diabetes and cardiovascular diseases. Age was significantly correlated with systolic BP ( r = 0.31), diastolic BP ( r = 0.30) and RBS ( r = 0.26). Furthermore, significant correlations were found between the duration of diagnosis with systolic ( r = 0.26) and diastolic ( r = 0.21) BP. None of the correlations between stress and the other study variables were significant.

Conclusion

Screening of antipsychotic side effects is needed in the early phases, and attention must be paid to the cardiovascular risk in patients with schizophrenia, particularly BP, glucose level and BMI. In addition, clinicians should be informed of this evidence to set guidelines for regular monitoring of metabolic parameters. Reporting Method STROBE guidelines were followed in this study. Patient or Public Contribution Actively involving patients in data collection, this study ensured that their voices were heard and their experiences were central to informing the research findings. In addition, involving patients in the study would enhance the relevance and applicability of the study's conclusions to real‐world contexts, promoting patient‐centered care and improved health outcomes for patients with schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsSchizophreniaHeart Disease Risk FactorsCardiovascular DiseasesPsychological DistressHumansMaleFemaleCross-Sectional StudiesAdultMiddle AgedRisk FactorsSurveys and QuestionnairesBody Mass Index

Stichwörter der Autor:innen

antipsychoticcardiovasculardistressschizophrenia

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Faculty of Nursing, Jordan University of Science and Technology, Irbid, Jordan.
  • King Abdullah University Hospital, Irbid, Jordan.
  • The Hashemite University, Zarqa, Jordan.
  • Al al-Bayt University-Princess Salma Faculty of Nursing, Mafraq, Jordan.
  • Faculty of Nursing, Yarmouk University, Irbid, Jordan.

ORCID-Profile: Tariq N Al-Dwaikat, Shaher H Hamaideh, Haitham Khatatbeh

Förderung

  • Deanship of Research, Jordan University of Science and Technology

Zitieren

APA

Al-Dwaikat, T. N., Al-Samouri, H. K., Dalky, H., Hamaideh, S. H., ALBashtawy, M., & Khatatbeh, H. (2025). Psychological Distress, Antipsychotic Medications and Cardiovascular Risk Factors Among Patients With Schizophrenia. Journal of Clinical Nursing, 34(9), 3908-3919. https://doi.org/10.1111/jocn.17606

Vancouver

Al-Dwaikat TN, Al-Samouri HK, Dalky H, Hamaideh SH, ALBashtawy M, Khatatbeh H. Psychological Distress, Antipsychotic Medications and Cardiovascular Risk Factors Among Patients With Schizophrenia. Journal of Clinical Nursing. 2025;34(9):3908-3919. doi:10.1111/jocn.17606

BibTeX
@article{AlDwaikat2025,
  author = {Al-Dwaikat, Tariq N and Al-Samouri, Haya Khader and Dalky, Heyam and Hamaideh, Shaher H and ALBashtawy, Mohammed and Khatatbeh, Haitham},
  title = {Psychological Distress, Antipsychotic Medications and Cardiovascular Risk Factors Among Patients With Schizophrenia},
  journal = {Journal of Clinical Nursing},
  year = {2025},
  volume = {34},
  number = {9},
  pages = {3908--3919},
  doi = {10.1111/jocn.17606}
}
Kostenlos starten →